American Home Products

Maryland U.S. Attorney is investigating Wyeth-Ayerst's "adverse events reporting system and the reporting of adverse events related to Redux and Pondimin," AHP discloses in Securities & Exchange Commission filing. AHP "is in the process of responding to the subpoena and continues to believe that its conduct with respect to the diet drugs has at all times been lawful and appropriate"